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Background: Cartilage tissue engineering offers new strategies in repairing damaged cartilage. Scaffolds have been
used for the in vitro and in vivo procedures for this application, which demonstrates the compatible biological and
physical properties that mimic natural tissues. Several types of scaffolds were used and had different effects on cell
functions. The study was designed to develop a functional gelatin scaffold by adsorption of hyaluronan (HA) and
the transforming growth factor β3 (TGF-β3) in a commercially available gelatin scaffold.
Results: The biological properties of human articular chondrocytes were investigated during a 21-day cultivation
embedded in either HA + TGF-β3 adsorbed scaffolds or the conventional supplemented method. The rising of
proliferation of chondrocytes embedded in adsorbed scaffolds was observed at day 17 and 21 of cultivation (1.27 and
1.28 fold, respectively). The chondrogenic gene expression of the chondrocytes embedded in HA + TGF-β3 adsorbed
scaffolds significantly increased: SOX-9 (1.65 fold), ACAN (7.65 fold) and COL2A1 (1.83 fold). Remarkably, over the 21 days
of cultivation, HA + TGF-β3 adsorbed scaffolds promoted the extracellular matrix molecules production with
higher accumulation of HA (1.2 fold), collagen (1.42 fold) and uronic acid (1.41 fold). Moreover, the cell population
and extracellular matrix production, which were examined by a histological analysis and a scanning electron
microscope, were correlated with the biochemical analysis.
Conclusion: A small amount of HA and TGF-β3 initially adsorbed in the scaffolds (70 μg and 10 ng, respectively)
was consumed over the 21-day cultivation. The HA + TGF-β3 adsorbed gelatin scaffold is effective and more suitable
than the conventional supplemented method for the in vitro assessment of human chondrocyte 3D culture.
Keywords: Gelatin scaffold, Human articular chondrocytes, Extracellular matrix, HA, TGF-β3, Cartilage tissue engineeringBackground
Chondral defects can lead to long term cartilage and
bone degeneration, if they are not diagnosed and treated.
Chondrocytes have a limited capacity for self-repair.
Damage frequently results in developmental abnormalities
or age related degeneration, such as osteoarthritis [1]. A
current approach for regenerative treatment is Autologous
Chondrocyte Implantation (ACI) [2-4]; however, this* Correspondence: prachya.kongtawelert@gmail.com
1Thailand Excellence Center for Tissue Engineering and Stem Cells, Faculty of
Medicine, Chiang Mai University, Intravarorot Road, Sripoom, Chiang Mai
50200, Thailand
Full list of author information is available at the end of the article
© 2014 Klangjorhor et al.; licensee BioMed Ce
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.technique is limited by the number of cells available, size
of the defects, and the need to maintain fully-differentiated
chondrocyte functions.
Tissue engineering has been introduced as a treatment
for cartilage damage because of its potential to enhance
and improve the efficacy of ACI. It has been developed
for restoring, maintaining, and enhancing tissue or organ
function [5-8]; moreover, culturing isolated cells on
biocompatible and biodegradable scaffolds ex vivo can
generate tissue for in vivo implantation [9].
A variety of biodegradable polymers have been explored
for cartilage repair, such as collagen sponges [10-12],ntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Scaffolds provide a three-dimensional (3D) environment
that promotes chondrogenesis, prevents dedifferentiation,
and helps in the recovery of the fully-differentiated chon-
drocyte phenotype, which is lost in a two-dimensional (2D)
culture [18-21]. Previously, it has been reported that a
gelatin-based scaffold (SPONGOSTAN® Standard, Johnson
& Johnson) is suitable for use as an in vitro model for
chondrocyte 3D culture [1,22]. There are several factors
that affect the quality of cartilage generated in tissue cul-
ture, including the type of scaffold material used, the qual-
ity of the chondrocytes, and the culture media including
growth factors [1]. In hyaline cartilage, hyaluronan (HA)
plays important roles in the skeletal network and provides
stability to the extracellular matrix molecules assembling
through interaction with other matrix components and
chondrocytes. HA promotes chondrocyte proliferation,
morphology, and migration, and it provides a controlled
environment suitable for cell growth and tissue formation
[1,8]. The application of HA for cartilage tissue engineering
has been studied. Either adding HA into the culture media
or exogenous HA-treated scaffolds has been reported to
provide positive effects for chondrocyte growth and dif-
ferentiation [1,8,12]. In conventional techniques, chon-
drocytes/scaffolds are cultured in chondrogenic media
supplemented with growth factors. TGF-β3 is one of the
growth factors studied, and it can induce the expression
of anabolic chondrogenic gene markers such as α1-
Collagen type II (COL2A1) and cartilage oligomeric
matrix protein (COMP), leading to induction of extracel-
lular matrix production [23,24]. However, large amounts
of TGF-β3 are needed as frequent media changes require
constant replacement.
The scaffold chondrogenic growth factors and bio-
chemical stimuli have been shown to be important fac-
tors for cartilage tissue engineering. Therefore, this
study sought to determine whether a HA/TGF-β3 phys-
ically immobilized scaffold could retain or enhance
chondrogenic properties required for cartilage trans-
plantation better than the scaffold with soluble growth
factors. The chondrogenic properties were investigated
with primary human articular chondrocyte culture by
examining cell proliferation and extracellular matrix pro-
duction as well as by using scanning electron micros-
copy and a histological examination. The expression of
anabolic chondrogenic genes was also measured over a
period of a 21-day cultivation.
Results
Amount of TGF-β3 and HA in cultivation
The chondrogenic media for the non-adsorbed scaffold
control was supplemented with the same amounts of
TGF-β3 (10 ng/ml) and HA (70 μg/ml) as in the con-
ventional method. During the cultivation, the mediumwas changed every 3 days. Thus, the total amounts of
TGF-β3 and HA used in this soluble control group were
60 ng and 420 μg respectively (Table 1). This contrasted
with the adsorbed scaffold group in which the total
amounts of TGF-β3 and HA used were only that
adsorbed on the scaffold. By using an adsorbed scaffold,
the use of TGF-β3 and HA was reduced by more than
80%. In order to investigate the release profile of HA
and TGF-β3 adsorbed to the scaffold, the HA and TGF-
β3 were quantified in the culture media of controlled in-
cubations (scaffold control). Interestingly, more than 90%
of the TGF-β3 and HA remained on the scaffold after
21 days. The data showed that the gelatin scaffold could
adsorb HA and TGF-β3, so that the culture showed only a
slow rate of release.Cell proliferation on gelatin scaffolds
The cell viability and proliferation of chondrocytes-
cultured scaffolds were determined on days 1, 3, 7, 10,
14, 17 and 21, by the Alamar Blue (resazurin based)
assay by comparing the groups of non-adsorbed scaf-
folds (PBS control), single factor adsorbed scaffolds (HA
adsorbed and TGF-β3 adsorbed scaffolds), combined
factors adsorbed scaffolds (HA + TGF-β3 adsorbed scaf-
folds) and non-adsorbed scaffolds in medium supple-
mented with soluble HA and TGF-β3 (soluble control).
The results showed that the number of cells on days 1
to 10 showed some decline in all cultures and were con-
sidered to be a lag phase, whereas days 10 to 17 showed
rapid growth, suggesting an exponential or logarithmic
phase (Figure 1). The highest survival rate of cells in the
cell-seeded soluble control scaffolds was observed earlier
on, during days 1 to 7. After day 10, the HA + TGF-β3
adsorbed scaffolds showed higher cell proliferation when
compared with soluble control on days 17 and 21 (p < 0.05
and p < 0.01 respectively). Only HA +TGF-β3 adsorbed
scaffolds had significantly increased cell proliferation more
than the PBS control on days 17 (1.34 fold, p < 0.01) and
21 (1.33 fold, p < 0.01). Moreover, increased cell prolifera-
tion was observed in cells seeded through the adsorption
of HA, HA +TGF-β3 adsorbed scaffolds, and soluble con-
trol scaffolds, but not in TGF-β3 adsorbed scaffolds. This
data suggested that HA could maintain cell proliferation,
and the combination of HA and TGF-β3 was efficient for
enhanced cell proliferation.Expression of cartilage-specific extracellular matrix
biomolecules
The chondrogenic activity of the chondrocyte-seeded
scaffolds was assessed by determining the production of
a hyaline-like extracellular matrix including HA and s-
GAG. The cell-free scaffolds were cultured and deter-
mined for HA release in order to compare them to the
Table 1 Amount of biomolecules used in cultivation and quantification of adsorbed HA and TGF-β3 within gelatin
scaffolds at day 21 of cultivation
Name of experimental group Amount of biomolecules used
in curtivation
Amount of biomolecules remained in scaffolds at
day 21
TGF-β3 (ng) HA (μg) TGF-β3 (ng) HA (μg)
PBS control - - - -
Soluble control (X 6 times of culture media exchange) 60.0 420.0 - -
HA adsorbed scaffold - 70.0 - 67.24 ± 0.37 (96.06 ± 0.53%)
TGFβ3 adsorbed scaffold 10.0 - 9.48 ± 0.098 (94.8 ± 0.98%) -
HA + TGFβ3 adsorbed scaffold 10.0 70.0 9.71 ± 0.11 (97.1 ± 1.10%) 66.12 ± 0.23 (94.46 ± 0.32%)
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the Methods section).
For each 3-day interval, the chondrocyte-seeded gel-
atin scaffolds showed higher levels of HA production
and HA release into the media than monolayer cultures
(Figure 2A). At days 7 to 21, the HA + TGF-β3 adsorbed
scaffolds showed significantly increased HA release
when compared with monolayer cultures and PBS con-
trol. The soluble control showed a significantly higher
HA release than that of HA + TGF-β3 adsorbed scaffolds
at day 7 (p = 0.032) and day 10 (p = 0.103). However in
the late period of the cultivation, HA release in the sol-
uble control was significantly lower than that of HA +
TGF-β3 adsorbed scaffolds on day 17 (p = 0.001). The
HA in culture media was more significantly increased
(Figure 2B) in cell-seeded gelatin scaffolds than in
monolayer cultures. In the HA + TGF-β3 adsorbed scaf-
folds, the HA was significantly higher than both PBS
control (1.65 fold and p < 0.01) and soluble controlFigure 1 Cell proliferation analysis of chondrocytes cultured in gelati
and 21 of cultivation. This data represents three separate experiments (n =
amount compared to the PBS control; # is a significant amount comparedscaffolds (1.15 fold and p = 0.021). The production and
release of s-GAG was determined (Figures 2C and 2D)
for each of the 3-day intervals. The levels of s-GAG for
chondrocyte-seeded soluble control and all types of
adsorbed scaffolds were significantly higher than that of
monolayer cultures, although there was no difference in
the s-GAG released on each day amongst these groups
(Figure 2C). However, the levels of s-GAG which accu-
mulated (Figure 2D) in adsorbed scaffolds were slightly
higher than those in soluble controls. Of important note is
the observation that the HA +TGF-β3 adsorbed scaffolds
showed the highest accumulation (81,967 ± 2,894 ng/μg
DNA content.
To support this analysis, the process of quantifying the
cartilage specific extracellular matrix in cultured scaf-
folds was performed, including the amounts of HA, s-
GAG, uronic acid, and collagen content (Figure 3). After
the 21-day cultivation, the levels of ECM production of
chondrocytes cultured in scaffolds were significantlyn scaffolds. Cell proliferation was examined on days 1, 3, 7, 10, 14, 17
3). *, # p-values are < 0.05; **, ## p-values are < 0.01; * is a significant
to the soluble control.
Figure 2 Glycosaminoglycans concentration in chondrocyte-seeded adsorbed scaffold culture media. Human articular chondrocytes were
cultured for 21 days, and Glycosaminoglycans, which were released into the culture media, were measured at 3-day intervals (A). HA accumulation in
the culture media (B). s-GAG released into the culture media at 3-day intervals (C). s-GAG accumulation in the culture media (D) were measured
(n = 3). *, # p-values are < 0.05; **, ## p-values are < 0.01; * is a significant amount compared to the PBS control; # is a significant amount
compared to the soluble control.
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uble control and all adsorbed scaffolds showed signifi-
cantly increased amounts of HA in scaffolds compared
to the amounts found in PBS control (Figure 3A), and
the amounts found in HA + TGF-β3 adsorbed scaffolds
were not different from those in the soluble control. The
matrix s-GAG content was more abundant in all scaf-
folds than in monolayer cultures, although the values
were not different between the various types of scaffolds
(Figure 3B).
The amounts of collagen in soluble control and
adsorbed scaffolds were higher than in the PBS control
scaffolds (Figure 3C), and the HA + TGF-β3 adsorbed
scaffolds showed the highest amounts and were signifi-
cantly higher than those found in the soluble control
(1.42 fold and p = 0.046).
At the end of the 21-day cultivation, the amount of ur-
onic acid in the matrix was measured. It was found that
in soluble control and adsorbed scaffolds, it was signifi-
cantly higher than in the PBS control (p < 0.01 for all
groups (Figure 3D)). In addition, HA and HA + TGF-β3
adsorbed scaffolds had significantly increased levels
compared to the level of the soluble control (1.30 and
1.41 fold respectively and p < 0.01 in both scaffolds).
This extracellular matrix production data suggested thatthe combination of HA and TGF-β3 adsorbed on the
gelatin scaffolds had improved efficiency in enhancing
cartilage-specific extracellular matrix production when
compared to the method of adsorbing HA or TGF-β3
alone.
Expression of anabolic chondrogenic mRNA profile of
cells on scaffolds
To test further whether the adsorbed scaffolds demon-
strated better potency of chondrogenic properties than
non-adsorbed scaffolds, the chondrogenic gene expres-
sion was quantified, including SOX-9 (SOX9), Aggrecan
core protein (ACAN), Collagen type II (COL2A1) and
Collagen type I (COL1A2) by real-time RT-PCR. The
mRNA expression levels were monitored on day 7 of the
21-day cultivation. SOX9 expression showed a fall in all
cultures from days 7 to 14 during the rapid proliferation
of the cells and remained decreased until the end of the
cultivation. However, the expression in HA, HA +TGF-β3
adsorbed and soluble control scaffolds on day 7 was
significantly higher than in the PBS control scaffolds
(p < 0.01, p < 0.05 and p < 0.05 respectively) (Figure 4A).
On day 14, the SOX9 expression in all adsorbed scaf-
folds and soluble control scaffolds was higher than in
the PBS control, but this was not significant. However,
Figure 3 Cartilage-specific extracellular matrix production in monolayer cultures and gelatin scaffolds. Human articular chondrocytes
were cultured on scaffolds for 21 days and then digested with papain. The papain digests were assayed for cartilage extracellular matrix components
including HA (A), s-GAG (B), collagen (C) and uronic acid (D) content. *, # p-values are < 0.05; **, ## p-values are < 0.01; * is a significant amount
compared to the PBS control; # is a significant amount compared to the soluble control.
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showed significantly increased SOX9 expression when
compared to the expression in the soluble control (p < 0.01
and p = 0.046). Aggrecan (ACAN) expression also paral-
leled some of the changes in SOX9 (Figure 4B), but com-
parisons showed that the HA +TGF-β3 adsorbed scaffolds
had a marked-up regulation of ACAN expression at day
7 and day 21 when compared to that of the PBS control
(p < 0.01 and p < 0.01) and the soluble control (p = 0.042
and p < 0.01). This correlated with the SOX9 expression at
these same time intervals. On day 21, the level of ACAN
expression in all adsorbed scaffolds and soluble control
scaffolds was significantly higher than in the PBS control
(p < 0.01 for all groups). As for Collagen type II (COL2A1),
the expression did not follow the pattern shown for SOX9
and ACAN, and there was no decrease shown from days 7
to 14. At day 21, the expression of COL2A1 in the
chondrocyte-seeded adsorbed scaffolds and soluble
control was significantly higher than in the PBS control
(p < 0.01 for all groups (Figure 4C)). Only the expression
in the TGF-β3 and HA+TGF-β3 adsorbed scaffolds were
significantly higher than in the soluble control on day 21
(p < 0.01 in both groups). All of the adsorbed scaffolds
showed an increase of COL2A1 expression after the 7-day
interval while that of the PBS control decreased.Furthermore, an investigation was made into the ratio of
Collagen type II (COL2A1) to Collagen type I (COL1A2)
gene expression as a measure of chondrocyte phenotype
(Figure 4D). All gelatin scaffolds showed higher ratios of
COL2A1 to COL1A2 than in monolayer cultures. The ra-
tio was at its highest on day 14 and decreased at day 21.
The ratio measured in chondrocyte-seeded HA +TGF-β3
adsorbed scaffolds was significantly higher than that of the
PBS control and soluble control at both day 14 and 21.
Histology examination of chondrocytes cultured on scaffolds
The cell penetration and morphology of chondrocyte-
seeded scaffolds by hematoxylin & eosin staining was de-
termined in this study (Figure 5A). The HA + TGF-β3
adsorbed scaffolds showed plentiful cell penetration and
growth in both the edge (higher panel) and porous areas
(lower panel). The HA adsorbed scaffolds showed less
cell distribution than that of the HA + TGF-β3 adsorbed
scaffolds. The other scaffold types, including the PBS
control, soluble control, and TGF-β3 adsorbed scaffolds,
showed less cell growth and distribution within the
scaffolds.
To determine the extracellular matrix production,
scaffolds were stained with Safranin O for glycosamino-
glycans and with immunohistochemistry for Collagen
Figure 4 Quantitative real-time RT-PCR analysis of chondrocytes cultured in gelatin scaffolds. The results represent the chondrogenic
specific gene markers, including SOX-9 (A), Aggrecan core protein (B), Collagen type II (C) and the ratio of Collagen type II/Collagen type I (D).
This data represents three separate experiments (n = 3). *, # p-values are < 0.05; **, ## p-values are < 0.01; * is a significant amount compared to
the PBS control; # is a significant amount compared to the soluble control.
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HA + TGF-β3 adsorbed scaffolds had higher amounts of
Safranin O staining when compared to the amounts in
the other scaffolds with the same observation of Colla-
gen type II intensity (shown in brown).
The results showed that the HA + TGF-β3 adsorbed
scaffolds were the best at enhancing cell proliferation
and extracellular matrix production.
Scanning electron microscopic examination
To assess cell morphology and cell distribution further, a
scanning EM was used on scaffolds at the end of the 21-
day cultivation. This examination showed that there was
a complete filling of the extracellular matrix formation
in the pores of both soluble control and HA + TGF-β3
adsorbed scaffolds (Figure 6). The surface of HA +TGF-
β3 adsorbed scaffolds were also covered with the chondro-
cytes embedded in extracellular matrix. The chondrocytes
showed a spherical morphology comparable with a previ-
ous study [25]. The surface of the soluble control scaffolds
was smoother than that of HA +TGF-β3 adsorbedscaffolds, and the distinct cell morphology could not be
observed.
TGF-β3 released over 21 days in culture media
The release of TGF-β3 in culture media of TGF-β3 and
HA+TGF-β3 adsorbed scaffolds was quantified and com-
pared. Figure 7A shows that the amount of TGF-β3 re-
leased from the HA +TGF-β3 adsorbed scaffolds was
lower than from the TGF-β3 adsorbed scaffolds at day 1.
Furthermore, the accumulated amount of TGF-β3 re-
leased into the culture media of HA + TGF-β3 adsorbed
scaffolds was lower than that of the TGF-β3 adsorbed
scaffolds (518.21 ± 98.15 vs 289.98 ± 110.00 pg) (Figure 7B).
The results suggested that the gelatin scaffolds retained
much of the TGF-β3 over the 21 days because the amount
released was much less than 5 percent of the amount of
TGF-β3 used in the adsorbed solution (10,000 pg).
Discussion
Gelatin is a natural polymer that has been used in cartil-
age tissue engineering and for cell delivery in cartilage
Figure 5 Histological examination of chondrocyte-seeded gelatin scaffold cultures after 21 days. Hematoxylin and Eosin staining (A) for
cell morphology and distribution; arrow indicates cells. Safranin O staining (B) for glycosaminoglycans production and immunohistochemistry for
collagen type II production (C).
Figure 6 Scanning electron microscopic examination of chondrocyte-seeded gelatin scaffolds. A Scanning electron microscope was used
on the surface of the cell-free gelatin scaffolds, chondrocyte-cultured HA + TGF-β3 adsorbed scaffolds, and soluble control scaffolds on days 0, 7
and 21 of cultivation. Images are at 35x and 500x insets.
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Figure 7 TGF-β3 release analysis in culture media of chondrocyte-seeded TGF-β3 adsorbed scaffolds and HA+ TGF-β3 adsorbed scaffolds.
The amounts of TGF-β3 in culture media on days 1, 3, 7, 10, 14, 17 and 21 of cultivation (A) and its accumulation (B) were examined. This data
represents three separate experiments (n = 3). *p-values are < 0.05.
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suitable because of its lack of antigenicity and retainment
of some informational signals, such as the RDG sequence,
which can promote cell adhesion, differentiation, prolifera-
tion [30,31], and ECM deposition [32]. Absorbable haemo-
static porcine gelatin scaffolds, commercially available as
SPONGOSTAN®, were obtained from Johnson & Johnson
(Denmark). They are medical devices used for haemostatic
surgical procedures. They are recommended as being a
suitable 3D matrix for chondrocytes [1,22,33] in order to
reduce dedifferentiation of the cells in vitro and to
stabilize the chondrocyte phenotype.
Even though HA-adsorbed gelatin (SPONGOSTAN®)
scaffolds [1] and TGF-β3 supplementation in chondro-
genic media [22] have previously been investigated for car-
tilage tissue engineering, this study worked on the new
development of combining the effect of both adsorbed ex-
ogenous HA and TGF-β3 on chondrocytes in a 3D culture
model. This study demonstrated for the first time that the
combination of HA and TGF-β3 adsorbed on gelatin scaf-
folds enhanced the extracellular matrix production and
chondrogenic specific gene markers of the embedded pri-
mary human chondrocytes.
In this work, gelatin scaffolds were used to mimic a
natural extracellular matrix by adsorbing to it the key
biomolecules, HA and TGF-β3. This provides a novel
factor delivery technique, the adsorption method. The
gelatin scaffolds have the ability to enhance cell adhesion
and growth by sustaining the release of growth factors
[34], which help to simplify the cartilage tissue regener-
ation process. Moreover, the amount of the stimulatingfactors and thereby the costs involved become 80% less
by using adsorbed scaffold cultures over conventional
media supplements.
Previous studies on TGF-β3 suggest that a dose of
10 ng seems to be sufficient to enhance chondrogenesis
in 2D and 3D in vitro cultures [35-38]. A scaffold con-
trol was performed to determine the amount of HA and
TGF-β3 released. The data showed that after day 21 of
cultivation, the amount of TGF-β3 remained at more
than 90 percent of the dose used in the scaffold adsorp-
tion process (10 ng).
Gelatin scaffolds were evaluated for 3D chondrocyte
cultures for in vitro hyaline cartilage tissue regeneration,
which used primary human articular chondrocytes. The
cell proliferation, extracellular matrix biomolecule con-
tent, and histological analysis were designed to deter-
mine the effects of HA and TGF-β3 adsorbed gelatin
scaffolds on chondrocyte ECM synthesis over the course
of the 21-day cultivation. Primarily, at the early stage of
cultivation, there was some decline in cell numbers as
the cells adapted to being on the matrix, but in compari-
son with the soluble control scaffolds, the combined
adsorbed scaffolds provided the highest cell retention rates
(days 1–7). At later stages of cultivation, HA +TGF-β3
adsorbed scaffolds tended to increase in cell proliferation
more than other types (days 10–21), whereas the prolifera-
tion of cells in soluble control and HA adsorbed scaffolds
were lower. These results correspond with previous studies
that showed HA to effectively promote chondrocyte prolif-
eration [8]. Because HA is a major component of ECM
produced by chondrocytes, it provides an appropriate
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Chondrocytes bind to HA via CD44-HA receptor interac-
tions and activate CD44 signaling pathways that play a role
in the proliferation of chondrocytes [8]. Although previous
studies [39] show that TGF-β3 stimulates cell proliferation,
this study, in contrast, found that TGF-β3 adsorbed scaf-
folds could not promote cell proliferation as well as control
scaffolds (Figure 1). However, HA +TGF-β3 adsorbed and
soluble control scaffolds had higher cell proliferation rates
than HA adsorbed scaffolds. These observations indicated
that cell attachment via HA may provide better access to
TGF-β3, thus allowing TGF-β3 to enhance HA function,
and possibly, HA might retain TGF-β3 on the scaffold
which enhances chondrocyte functions. These results cor-
related with the H&E staining that took place after the 21-
day cultivation (Figure 5A). The staining showed large
numbers of cells in the pores and on the surface of HA +
TGF-β3 adsorbed scaffolds. In cartilage tissue engineering,
cell proliferation (viability) is important to achieve tissue
regeneration [2-4]. Since chondrocytes were used as the
primary cells in this study, any small increase in their pro-
liferation might be meaningful data for ECM production.
This study demonstrated that chondrocytes seeded in the
HA+TGF-β3 adsorbed scaffolds expressed chondrogenic-
specific extracellular matrix biomolecules, including HA,
collagen, and uronic acid more than chondrocytes cultured
in other types of gelatin scaffolds. HA not only promotes
cell adhesion and proliferation, but also provides positive ef-
fects on chondrocyte differentiation [1,8,12]. In addition,
TGF-β3 can induce cell differentiation by stimulating the
expression of anabolic chondrogenic gene markers, leading
to extracellular matrix production [9,10]. According to the
Safranin O and Collagen type II staining (Figures 5B and C),
HA and TGF-β3 enhance extracellular matrix production.
The expression of chondrogenic genes on days 7, 14
and 21 of cultivation were also examined. On day 7,
chondrocytes cultured in HA, HA + TGF-β3 adsorbed,
and soluble control scaffolds expressed higher levels of
SOX9 and ACAN than those cultured in PBS control.
And on day 14, the decreased expressions of these two
genes were observed. The SOX9 transcription factor
plays a role in the induction and retainment of the chon-
drogenic phenotype and cartilaginous matrix formation
[40]. It is also known to regulate the expression of
ACAN [41] and COL2A1 [42] genes, which encode im-
portant cartilage-specific matrix proteins. Nevertheless,
both chondrocytes seeded in all of the adsorbed gelatin
scaffolds and in the soluble control scaffolds showed an
increase in the amount of COL2A1 expression on day
21, which occurred after the decrease of the SOX9 ex-
pression on day 14. These results indicate that COL2A1
is under the regulation of other factors besides SOX9.
On days 14 and 21 of cultivation, the chondrocytes that
were seeded in all of the adsorbed scaffolds and in thesoluble control expressed higher levels of COL2A1 ex-
pression than the chondrocytes in the PBS control
group, and moreover, chondrocytes cultured in HA +
TGF-β3 adsorbed scaffold groups showed the highest
expression overall. A ratio of COL2A1 to COL1A2 is
generally used for assessment of chondrocyte phenotypic
stability. The COL2A1/COL1A2 ratio of chondrocytes
seeded in HA + TGF-β3 adsorbed scaffolds and in the
soluble control was significantly higher than the ratio in
the PBS control group on day 14. On day 21 of cultiva-
tion, the COL2A1/COL1A2 ratio of chondrocytes cul-
tured in HA + TGF-β3 adsorbed scaffolds was higher
than in the soluble control group. The previous studies
demonstrated that type II collagen gene expression level
in native cartilage was markedly higher than in cultured
chondrocytes, besides type I collagen gene expression
was markedly increased in culture compared to intact
cartilage [43,44]. Moreover, they found that type II colla-
gen gene expression exhibited decrease during mono-
layer cultivation [43]. These evidences indicated that the
COL2A1/COL1A2 ratio was extremely low in chondro-
cyte cultivation when compares to intact cartilage. Cor-
responding to our study, the COL2A1/COL1A2 ratio of
the cultured chondrocytes was very low in monolayer
culture and it was elevated by cultivation in scaffold,
however, still lower than in intact cartilage.
These observations suggest that the HA +TGF-β3
adsorbed gelatin scaffolds support dedifferentiation less
than and enhance re-differentiation more than the chon-
drocytes in the monolayer cultures, and therefore, it indi-
cates that they have potential to stabilize the chondrocyte
phenotype. These results also indicate that HA and TGF-
β3 have anabolic effects on chondrocytes as presented in
previous studies [8,23]. They have these effects by pro-
moting the expression of chondrogenic gene markers.
Interestingly, HA and TGF-β3 showed a synergistic ef-
fect on the retention of chondrogenic properties including
enhanced anabolic chondrogenic gene expressions and
cartilage matrix proteins production, including HA, pro-
teoglycan, collagen, and uronic acid.
The soluble control scaffolds induced chondrocyte
proliferation, ECM production, and chondrogenic anabolic
gene expression only during the early period of cultivation.
Moreover, these scaffolds showed large amounts of cell
proliferation only on the surface of the scaffolds (Figure 5A)
but not in the pores of the scaffolds. These observations
indicate that soluble HA and TGF-β3 mainly enhance cell
proliferation and ECM production of chondrocytes around
surface of scaffold, whereas HA +TGF-β3 adsorbed scaf-
fold may induce those in both surface and inside pore of
scaffold. Secondly, because the ECM was abundantly pro-
duced and tightly covered the scaffolds, TGF-β3 and HA
were not able to pass through the ECM layer in order to
maintain the chondrocyte function inside the scaffolds.
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adsorbed scaffolds had higher rates of TGF-β3 retain-
ment than those of TGF-β3 adsorbed scaffolds. Thus,
HA in HA + TGF-β3 adsorbed scaffolds may be what re-
tains the growth factor TGF-β3 within the scaffolds and
helps present the fiber network of HA and TGF-β3 in
order to interact and enhance the chondrocyte functions
[45]. Evidence suggests that in vivo TGF-β3 has a short
half-life and may be degraded by proteases and elastases
at sites of inflammation [46]. It is possible that TGF-β3 in
the adsorbed scaffolds might be degraded after 21 days.
However, in this study, HA and TGF-β3 adsorbed scaf-
folds showed more efficiency in supporting chondrocyte
functions and cartilage matrix regeneration than soluble
control scaffolds, which were supplemented with fresh
HA and TGF-β3. HA is glycosaminoglycan, it has viscous
properties, is highly hydrated, and is non-immunogenic.
Accordingly, HA has an important physical function. HA
maintains the viscosity of interstitial fluid in connective
tissue [47], controls water transport [48], and provides
protective physiochemical functions. Exogenous HA sup-
presses the production and activity of matrix metallopro-
teinases and pro-inflammatory mediators. Therefore, HA
has been explored as a drug delivery agent for several tar-
get tissues [49]. This study supports the idea that HA
could help retain TGF-β3 as a drug delivery agent in gel-
atin scaffolds.
Many previous studies have reported the comparison
between 2D and 3D culture methods on chondrogenic
phenotype and cartilage tissue regeneration [18-21,50].
2D monolayer cultivation has not maintained chondro-
genic differentiation gene markers, including SOX9,
ACAN, and COL2A1. This corresponds with a lower ex-
pression of cartilage extracellular matrix than what is
seen in 3D cultivation. In contrast, 3D cultivation is ac-
cepted as the way to help maintain the chondrocyte
phenotype by increasing both the chondrogenic mRNA
and extracellular matrix expression. Scaffolds provide a
3D environment in which cell-cell and cell-extracellular
matrix interactions are promoted, and they are likely to
be an important factor for chondrocyte functions in car-
tilage regeneration.
Conclusion
Chondrocyte dedifferentiation occurs in routine cultiva-
tion of 2D monolayer culture, and 3D culture can be
used to retain chondrogenic phenotypes. In this study, a
functional scaffold was developed based on a novel strat-
egy that enhances redifferentiation and promotes matrix
production in 3D culture. An investigation into this scaf-
fold design has shown that HA + TGF-β3 adsorbed scaf-
folds are suitable for supporting chondrocyte expansion
and the enhancement of extracellular matrix production,
including HA, s-GAG, uronic acid, and collagen. Inaddition, this functional scaffold gives improved expres-
sion of anabolic chondrogenic genes, including SOX9,
ACAN, and COL2A1, when compared to the control
groups. Since HA and TGF-β3 show a synergistic effect
on the induction of chondrogenic properties when
adsorbed onto HA + TGF-β3 adsorbed gelatin scaffolds,
it is believed that these scaffolds may offer advantages as
regenerative cartilage tissue models for in vitro 3D hu-
man chondrocyte culture.
Methods
Human articular chondrocyte preparation
Human articular cartilage from non-osteoarthritis joints
were collected during notchplasty operations from the
articular knee cartilage of 18-45 year old patients at
Maharaj Nakorn Chiang Mai Hospital, Chiang Mai,
Thailand. Chondrocytes were isolated and purified by
standard protocols as described below. All patients gave
consent, and all procedures of this study were approved
by the Research Ethical Committee, Faculty of Medicine,
Chiang Mai University, Thailand (the ethics approval
code was 070CT111016).
Cartilage was carefully cut away from the underlying
bone, and the chondrocytes were isolated by a collage-
nase digestion and then grown as monolayers in Dulbec-
co’s Modified Eagles medium (DMEM) containing 10%
(v/v) fetal calf serum (FCS), 100 U/ml penicillin and
100 μg/ml streptomycin until an 80% confluency was
reached. The cells were cultured in a humidified incuba-
tor with 5% CO2 at 37°C. DMEM, penicillin, strepto-
mycin, and FCS were purchased from Gibco (USA).
Collagenase was obtained from Calbiochem (Germany).
Preparation of HA/TGF-β3 was physically immobilized on
a gelatin scaffold by the adsorption method
The gelatin scaffolds SPONGOSTAN® were obtained from
Johnson & Johnson. Circular gelatin scaffolds were cut using
a metal borer or punch with a diameter of 5 mm. They were
sterilized by autoclave at 121°C, 15 pounds and 25 minutes.
For the adsorption process, the scaffolds were transferred to
a sterile 24-wells tissue culture plate and incubated with
100 μl solution of (a) 0.07% (w/v) HA (Viscoseal) in PBS
(adsorb-HA), (b) 100 ng/ml TGF-β3 (Peprotech, USA) in
PBS (adsorb-TGF-β3) or (c) 0.07% (w/v) HA and 100 ng/ml
TGF-β3 in PBS (adsorb-HA+TGF-β3) and incubated at
37°C for 4 hours. A control scaffold was adsorbed with PBS
alone in this step. For the soluble control group, the scaffold
was processed the same as the PBS control group, and sol-
uble 0.07% (w/v) HA and 10 ng/ml TGF-β3 were added dir-
ectly into culture media each time the media was changed.
Cell seeding and culture conditions
The primary human chondrocytes were expanded through
4 passages (P4), and cells were harvested at 80% confluency
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transferred to a sterile 24-wells tissue culture plate and
then 20 μl of 25×106 cells/ml cell suspensions (500,000
cells/scaffold) were directly seeded onto the scaffold and
left to attach at 37°C and 5% CO2 for 4 hours. After at-
tachment, 1 ml of DMEM with 10% FCS was added and
incubated at 37°C under 5% CO2 overnight. The next
day (day 0), the scaffolds were transferred to new cul-
ture wells, and 1 ml of chondrogenic media (DMEM,
10% FCS, 10−7 M dexamethasone, 25 μg/ml ascorbic
acid (Sigma, USA) and 1x insulin-transferrin-selenite
(ITS) supplement (Gibco, USA)) were added, and then
they were incubated at 37°C under 5% CO2 for up to
21 days. Culture media was changed and kept at 3-day
intervals for HA release analysis. Cells cultured in scaf-
folds on day 21 were digested at 60°C overnight with 2
units of papain. Papain digests were analyzed for cartil-
age extracellular matrix anabolism by determining the
content amount of HA, s-GAG, collagen, and uronic
acid. Additionally, the culture media were assayed for
the release of TGF-β3 growth factor.
Scaffold controls
For the scaffold controls, the scaffolds were cultured in
chondrogenic media without cells and incubated at 37°C
under 5% CO2. Culture media was changed and kept at
3-day intervals for HA and TGF-β3 release analysis
using enzyme linked immunosorbent assay (ELISA), and
was used as an indirect method to measure the levels at
which HA and TGF-β3 were adsorbed to the scaffold.
The amount of HA and TGF-β3 remaining on the scaf-
fold were determined by subtracting the amount of re-
leased HA and TGF-β3 in the culture media from the
original amount used in the adsorbed solution. This
method was necessary because the amount of HA and
TGF-β3 adsorbed onto the scaffold could not be de-
tected by ELISA. After 21 days, the scaffold controls
were digested by papain and analyzed for HA content in
order to normalize it with the production values of the
cell-seeded scaffolds.
Cell proliferation assay
Cell viability or proliferation was assessed by Alamar
Blue assay, following the supplier’s instructions [51].
Samples of the chondrocyte-seeded scaffolds were daily
incubated in media supplemented with 10% (v/v) Alamar
Blue fluorescent dye (Sigma, USA) for 4 hours at 37°C.
The adsorbance was measured at 570 and 600 nm by a
micro-plate reader spectrophotometer.
Assay of extracellular matrix (ECM) biomolecules
Hyaluronic acid
Hyaluronic acid which was released into the culture
media and then accumulated on the scaffolds wasexamined using a competitive inhibition-based, enzyme-
linked immunosorbent assay (ELISA) for HA as previ-
ously described [52]. Briefly, the samples or standards of
HA (Healon®) at various concentrations (19–10,000 ng/ml)
were incubated with biotinated hyaluronan-binding pro-
teins (B-HABPs) (1:200), diluted in 0.05 M Tris–HCl buf-
fer, pH 8.6 at room temperature for 1 hour, and then
added to the microplate, which was pre-coated with umbil-
ical cord HA overnight at 4°C (100 μl/well of 1 mg/ml HA)
and blocked with 1% BSA (150 μl/well) for 1 hour at room
temperature. The wells were subsequently washed and
100 μl of peroxidase-conjugated anti-biotin antibodies
(1:2,000 dilute in PBS) were added and incubated at room
temperature for 1 hour. The wells were subsequently
washed and 100 μl of peroxidase substrate were added and
incubated at room temperature for 10 minutes to allow the
color to develop. The reaction was stopped by using 50 μl/
well of 4 M sulfuric acid, and the absorbance was deter-
mined using a microplate reader spectrophotometer at
492/690 nm. The concentration of HA in the samples was
calculated with reference to a standard curve.
s-GAG
The assay is based on a metachromatic shift in absorp-
tion maximal from 690 nm to 535 nm as a complex
compound is formed in the mixture of 1,9-dimethyl-
methylene blue (DMMB) and the sulfated glycosamino-
glycan (s-GAG) in the samples and then compared to
standard chondroitin 6-sulfate (CS-C: shark cartilage ex-
tract) [53]. The DMMB solution was added to CS-C
standards, culture media samples, or papain digest solu-
tions, and then the absorbance values at 520 nm were
measured with a microplate reader spectrophotometer.
Collagen content determined by hydroxyproline assay
Papain-digested samples were hydrolyzed with 6 N HCl
for 24 hours at 60°C and neutralized with 12 N NaOH.
The samples or hydroxyproline standards were reacted
with freshly prepared oxidizing solution (Chloramine-T)
and further incubated for 5 minutes at room temperature.
After incubation, Ehrlich’s reagent was added, and the re-
action mixtures were incubated for 45–60 minutes at
60°C. The absorbance was measured at 570 nm by a
microplate reader spectrophotometer.
Uronic acid content determined by carbazole reaction
The uronic acid content in the scaffolds was analyzed
according to the release of the monosaccharide from gly-
cosaminoglycan in ECM by acid hydrolysis, and the re-
action with the carbazole reagent was detected at the
maximal adsorption at 540 nm in a microplate reader
spectrophotometer [54]. The papain-digested samples or
glucuronic acid standards were hydrolyzed with the sul-
furic acid-borate reagent at 100°C for 15 minutes and
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added, and the reaction took place at 100°C for 15 minutes
and then was cooled down in an ice bath. The absorb-
ance was measured at 540 nm by a microplate reader
spectrophotometer.
DNA content
The values of HA, s-GAG, collagen and uronic acid pro-
duction were normalized per cell with the DNA content.
Hoechst 33258 dye or bisbenzimide is a fluorescent dye
that binds to AT-rich regions of DNA, allowing it to be
used as a way to detect the quantities of DNA. Hoechst
33258 dye (Sigma, USA) is excited by ultraviolet light at
around 356 nm and emits a blue/cyan fluorescence light
with an emission wavelength of 465 nm [55]. Ten μL of
papain-digested samples or DNA standards from calf
thymus were diluted in 2 ml of dye/TNE buffer solution,
and the fluorescence of the samples was evaluated as de-
scribed above.
Chondrogenic anabolic gene expressions by quantitative
real-time RT-PCR
Total RNA from cultured scaffolds on days 7, 14, and 21
were extracted using an RNA extraction kit (GE Health-
care, UK), in accordance with the manufacturer’s proto-
col. 200 ng of total RNA were converted to cDNA using
RevertAid™ H minus first strand cDNA synthesis kit
(Fermentus Life science, USA). In order to determine
the chondrogenic gene expression, SYBR Green detec-
tion was used, and the values were normalized using
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). A
real-time quantitative polymerase chain reaction (PCR)
was performed in a DNA Engine (ABi 7500) using SYBR
GREENER qPCR UNIVERSAL (Invitrogen, USA). Primers
sequences are as follows: Aggrecan core protein (ACAN)
forward: 5′CTGTTCAGGGACAGAATGTGCT3′, Aggre-
can core protein (ACAN) reverse: 5′TCGATATGCTTCA
CAGTTCTAGGG3′, Collagen type I (COL1A2) forward:
5′TTTTGGCCATCTCTTCCTTCA3′, Collagen type I
(COL1A2) reverse: 5′TGTGGATGCCTC TTGGGTATC3′,
Collagen type II (COL2A1) forward: 5′TCCTCTTCT
TGAGCTGGACTCATTCT3′, Collagen type II (COL2A1)
reverse: 5′CGCTCTGCAAACTGGAGGTC3′, SOX9 for-
ward: 5′ GAAGGTGAAGGTCGGAGTC3′, SOX9 reverse:
5′GAAGATGGTGATGGGATTTC3′, GAPDH forward: 5′
GAAGGTGAAGGTCGGAGTC3′, GAPDH reverse: 5′
GAAGATGGTGATGGGATTTC3′. Relative expression
levels of each gene were calculated by normalizing them
with the expression of GAPDH by the 2-ΔCT method [56].
Histological immunohistochemistry
Scaffold section preparation
The cells cultured on the scaffolds for 21 days were fixed
in a solution of 4% paraformaldehyde and dehydratedthrough a graded ethanol series including 50%, 70%,
95%, 100% ethanol and xylene in the last step. Then the
cultured scaffolds were embedded in paraffin wax, casted
into blocks, and sectioned at a thickness of 5 μm [17].
Haematoxylin-eosin (H&E) staining
The sections were deparaffinized with xylene and rehy-
drated through a graded ethanol series including 95%
and 70% ethanol and PBS in the last step. The sections
were stained in a hematoxylin solution and counter-
stained with eosin. The stained sections were dehydrated
through a graded ethanol series and xylene and were
then mounted using mounting media.
Safranin O staining
Sections were stained with safranin O. This staining process
is used for the detection of cartilagesulfated glycosamino-
glycan as well as mast cell granules on paraffin-embedded
tissue sections. The sections were deparaffinized, rehy-
drated, and stained with safranin O for 30 minutes. The
stained sections were dehydrated and mounted [57].
Immunohistochemistry for collagen type II
In order to perform an immunohistological analysis of
collagen type II synthesis, after the sections were depar-
affinized and rehydrated, the sections were digested with
0.25% trypsin, 1.45 IU/ml testicular hyaluronidase and
0.25 IU/ml chondroitinase ABC for 15 minutes at 37°C
in each step, respectively. Then the sections were
blocked for the endogenous peroxidase with 3% H2O2 in
PBS, and the non-specific sites were blocked with 3%
BSA in PBS. The sections were incubated with mouse
monoclonal anti-collagen type II (1:100) for overnight at
4°C, followed by incubation with anti-mouse polyvalent
immunoglobulin conjugate HRP (1:25) for 1 hour at
room temperature. After washing with PBS, DAB solu-
tions were added as previously described [58].
Scanning electron microscopic examination
On days 0, 7 and 21, cultured scaffold samples were
washed twice with PBS and fixed in 0.1 M of phosphate-
buffer solution containing 3% glutaraldehyde overnight
at 4°C. Samples were dehydrated through a graded series
of ethanol and acetone until they reached their critical
point of drying using a CPD 7501 (critical point drier)
and then were mounted on stubs and sputtered with an
ultrathin layer of gold in a SEM-coating system using
SPI-MODULETM Sputter Coater. Specimens were stud-
ied using a JEOL 5910 LV SEM apparatus at an acceler-
ating voltage of 15 kV.
Quantification of TGF-β3
The amount of released TGF-β3 was quantified in
the culture media using the sandwich enzyme-linked
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ELISA kit, Koma biotech), in accordance with the manu-
facturer’s instructions.
Statistic analysis
Significance of differences between the groups of data was
determined using a one-way analysis of variance (one-way
ANOVA) test, and all groups were expressed as mean ±
SD. Statistical significance was assumed at p < 0.05. The
data represents three separate experiments (n = 3).
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